Mesoblast - ADR Key Ratios

$17.11

up-down-arrow $-0.19 (-1.07%)

As on 03-Sep-2026 12:37EDT

Market cap

info icon

$2,262 Mln

Revenue (TTM)

info icon

$65 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

4.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 0.00 1,526.81 1,053.16 104.39 32.03
EBIT 0.00 -41.71 -37.78 -0.81 6.08
Net Profit 0.00 16.21 8.69 -4.24 0.75
EPS 0.00 25.92 19.37 11.75 9.54
Book Value -- -- -6.24 -6.18 -13.30
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsJun-26Jun-25Jun-24
EBIT-Margin info -723.88-768.97---465.51-982.24
Net Margin info ----------
Return on equity info -15.58-16.01-9.86-18.95-17.91
Return on Capital info -12.92-13.26-8.89-15.42-14.45
Return on Assets info -11.53-11.97-7.38-14.05-13.14
Debt to Equity (x) info ------0.210.25
ROCE

-8.89

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
-8.89
-15.42
-14.45
-13.40
-14.15
Peer Median
--
--
--
--
--
ROE

-9.86

--

Profit after tax / Average Net worth * 100

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
-9.86
-18.95
-17.91
-16.40
-16.94
Peer Median
--
--
--
--
--
ROA

-7.38

--

Profit after tax / Average Total assets * 100

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
-7.38
-14.05
-13.14
-12.30
-12.99
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
--
-465.51
-982.24
-835.32
-792.80
Peer Median
--
--
--
--
--
Net Margin

-47.82

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
-47.82
-593.92
-1,490.27
-1,091.71
-894.59
Peer Median
--
--
--
--
--
Revenue Growth

5.99

--

Year on year growth in net sales

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
5.99
1.91
-0.21
-0.27
0.37
Peer Median
--
--
--
--
--
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
--
-38.10
7.48
22.60
8.96
Peer Median
--
--
--
--
--
Net Profit Growth

43.71

--

Year on year growth in profit after tax

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
43.71
-16.13
-7.41
10.35
7.55
Peer Median
--
--
--
--
--
EPS Growth

0.45

--

Year on year growth in earnings per share

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
0.45
-0.02
0.10
0.38
0.08
Peer Median
--
--
--
--
--
Debt to Equity

--

--

Total debt / Net worth

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
--
0.21
0.25
0.23
0.22
Peer Median
--
--
--
--
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
--
0.10
0.03
0.02
0.02
Peer Median
--
--
--
--
--
Current Ratio

2.43

--

Current Assets / Current Liabilities and Provisions

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
2.43
1.99
1.18
1.95
1.36
Peer Median
--
--
--
--
--
Quick Ratio

2.09

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
2.09
1.77
1.18
2.05
--
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
--
-3.49
-2.81
-3.22
-4.68
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

47.46

--

Debtors outstanding / Net Sales * 100

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
47.46
86.44
355.00
93.29
43.12
Peer Median
--
--
--
--
--
Asset Turnover

0.15

--

Sales / Average Total Assets

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
0.15
0.02
0.01
0.01
0.01
Peer Median
--
--
--
--
--
Receivable days

109.26

--

Average Debtors / Sales * 365

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
109.26
380.35
864.85
277.58
160.84
Peer Median
--
--
--
--
--
Inventory Days

551.78

--

Average Inventory / Sales * 365

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
551.78
791.94
-19.23
-28.76
-1.45
Peer Median
--
--
--
--
--
Payable days

587.20

--

Average Creditors / Cost of goods sold * 365

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
587.20
931.00
121.02
143.73
122.60
Peer Median
--
--
--
--
--
Cash Conversion Cycle

73.83

--

Receivable Days + Inventory Days - Payable Days

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
73.83
241.30
724.61
105.09
36.79
Peer Median
--
--
--
--
--
Price / Earnings

-30.40

--

Current share price divided by earning per share in the last twelve months

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
-30.40
-13.58
-8.69
-4.50
-1.58
Peer Median
--
--
--
--
--
Price / Book Value

3.08

--

Current share price divided by book value per share in the latest financial year

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
3.08
2.32
1.59
0.73
0.29
Peer Median
--
--
--
--
--
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Jun-26
Jun-25
Jun-24
Jun-23
Jun-22
Mesoblast - ADR
--
-18.38
-14.63
-7.07
-2.50
Peer Median
--
--
--
--
--
loading...
loading...